Recombinant Human Interleukin 2 (rHuIL-2)
Recombinant human interleukin-2 is a sterile protein product for injection. rHuIL-2 is produced by recombinant DNA technology using Yeast. It is a highly purified protein containing 133 amino acids, with cysteine mutated to alanine at 125 amino acid position, and has a molecular weight of approximately 15.4kD, non-glycosylated.
1.Indicated for the treatment of adults with metastatic renal cell carcinoma (metastatic RCC).
2.Indicated for the treatment of adults with metastatic melanoma.
Sterile, clear and colorless liquid for injection in vial.
Dosage: 3 million IU (0.3ml)/vial
Reference: Current CP/Internal
Specific activity: ≥1.7×107IU/mg
Purity (HPLC, SDS-PAGE): ≥98%
Active ingredient: Recombinant Human Interleukin 2 (rHuIL-2)
Inactive ingredients: Glacial Acetic Acid, Mannitol, Polysorbate-80 and Sodium Acetate.
lShelf life and storage conditions
|Storage at 2
|Drug Substance (Concentrated solution)||Storage at -70